Interleukin-6 and the determinants of severe COVID-19: A retrospective cohort study

Cytokines, notably interleukin-6 (IL-6), increase considerably in patients with severe corona virus disease 2019 (COVID-19). This vigorous immune response may cause end-organ failure or death; hence, measuring IL-6 in the context of patient characteristics may help predict outcomes and encourage ear...

Descripción completa

Detalles Bibliográficos
Autores principales: Hafez, Wael, Nasa, Prashant, Khairy, Ahmed, Jose, Mohan, Abdelshakour, Mahmoud, Ahmed, Sabah, Abdulaal, Fatema, Nair, Nivedita, Ahmad, Mohammad, Rashid, Vanya Jalal, Ayman, Youmna, John, Steffi, Fdl Alla, Osman, Abu Shady, Reham, Mohamed, Ahmed Ali, Soliman, Rami, Nader, Simon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
4900
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10637408/
https://www.ncbi.nlm.nih.gov/pubmed/37960722
http://dx.doi.org/10.1097/MD.0000000000036037

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10637408/
https://www.ncbi.nlm.nih.gov/pubmed/37960722
http://dx.doi.org/10.1097/MD.0000000000036037

Ejemplares similares